Optimization of patient and site engagement in the SYNCHRONIZE™ phase 3 clinical trial program for survodutide in obesity through clinical trial simulation
These results suggest participant and site staff input from a CTS could help improve obesity clinical trial design, which may ultimately lead to more robust data and reliable clinical findings.
Authors
- Vicki Mooney (ORCID: https://orcid.org/0000-0003-3648-4687)
- David Baanstra
- V. Van de Walle
- Wouter Daniëls
- Joe Nadglowski
- Christopher Recaldin
- Domenica M. Rubino
Institutions
- European Foundation for the Improvement of Living and Working Conditions (IE)
- Mining and Metallurgy Institute Bor (RS)
- Immunization Action Coalition (US)
- Washington Center for Weight Management and Research (US)
- Boehringer Ingelheim (Netherlands) (NL)
Publication Details
- Journal
- Contemporary Clinical Trials Communications
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.conctc.2026.101611
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00